Literature DB >> 11204055

Orexin (hypocretin)-like immunoreactivity in the cat hypothalamus: a light and electron microscopic study.

J H Zhang1, S Sampogna, F R Morales, M H Chase.   

Abstract

Orexin-A-like immunoreactive (OrA-ir) neurons and terminals in the cat hypothalamus were examined using immunohistochemical techniques. OrA-ir neurons were found principally in the lateral hypothalamic area (LHA) at the level of the tuberal cinereum and in the dorsal and posterior hypothalamic areas. In the LHA the majority of the neurons were located dorsal and lateral to the fornix; a small number of OrA-ir neurons were also present in other regions of the hypothalamus. OrA-ir fibers with varicose terminals were detected in almost all hypothalamic regions. The high density of fibers was located in the suprachiasmatic nucleus, the infundibular nucleus (INF), the tuberomamillary nucleus (TM) and the supra- and pre-mamillary nuclei. Ultrastructural analysis revealed that OrA-ir neurons in the LHA receive abundant input from non-immunoreactive terminals. These terminals, which contained many small, clear, round vesicles with a few large, dense core vesicles, made asymmetrical synaptic contacts with OrA-ir dendrites, indicating that the activity of orexin neurons is under excitatory control. On the other hand, the terminals of OrA-ir neurons also made asymmetrical synaptic contact with dendrites in the LHA, the INF and the TM. The dendrites in the LHA were both non-immunoreactive and OrA-ir; conversely, the dendrites in the INF and the TM were non-immunoreactive. In these regions, OrA-ir terminals contained many small, clear, round vesicles with few large, dense core vesicles, suggesting that orexinergic neurons also provide excitatory input to other neurons in these regions.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11204055     DOI: 10.1093/sleep/24.1.67

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  9 in total

1.  The injection of hypocretin-1 into the nucleus pontis oralis induces either active sleep or wakefulness depending on the behavioral state when it is administered.

Authors:  Mingchu Xi; Michael H Chase
Journal:  Sleep       Date:  2010-09       Impact factor: 5.849

Review 2.  Role of orexin receptors in obesity: from cellular to behavioral evidence.

Authors:  C E Perez-Leighton; T A Butterick-Peterson; C J Billington; C M Kotz
Journal:  Int J Obes (Lond)       Date:  2012-03-06       Impact factor: 5.095

3.  Distribution of hypothalamic neurons with orexin (hypocretin) or melanin concentrating hormone (MCH) immunoreactivity and multisynaptic connections with diaphragm motoneurons.

Authors:  Varun M Badami; Cory D Rice; James H Lois; Jayesh Madrecha; Bill J Yates
Journal:  Brain Res       Date:  2010-02-06       Impact factor: 3.252

4.  The effect of clomipramine on wake/sleep and orexinergic expression in rats.

Authors:  P Feng; Y Hu; D Li; D Vurbic; H Fan; S Wang; K P Strohl
Journal:  J Psychopharmacol       Date:  2008-06-18       Impact factor: 4.153

5.  Orexin-A inputs onto visuomotor cell groups in the monkey brainstem.

Authors:  S Schreyer; J A Büttner-Ennever; X Tang; M J Mustari; A K E Horn
Journal:  Neuroscience       Date:  2009-08-22       Impact factor: 3.590

6.  The hypocretins (orexins) mediate the "phasic" components of REM sleep: A new hypothesis.

Authors:  Pablo Torterolo; Michael H Chase
Journal:  Sleep Sci       Date:  2014-08-20

7.  Hypothalamic orexinergic neuron changes during the hibernation of the Syrian hamster.

Authors:  Jesús M López; Paula Carballeira; Javier Pozo; Gonzalo León-Espinosa; Alberto Muñoz
Journal:  Front Neuroanat       Date:  2022-09-09       Impact factor: 3.543

8.  Hypocretin/Orexin neuropeptides: participation in the control of sleep-wakefulness cycle and energy homeostasis.

Authors:  A Nuñez; M L Rodrigo-Angulo; I De Andrés; M Garzón
Journal:  Curr Neuropharmacol       Date:  2009-03       Impact factor: 7.363

Review 9.  An overview of the orexinergic system in different animal species.

Authors:  Idris A Azeez; Olumayowa O Igado; James O Olopade
Journal:  Metab Brain Dis       Date:  2021-07-05       Impact factor: 3.584

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.